BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33047950)

  • 1. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
    Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
    ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
    Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
    Oh JM; Rangarajan TM; Chaudhary R; Singh RP; Singh M; Singh RP; Tondo AR; Gambacorta N; Nicolotti O; Mathew B; Kim H
    Molecules; 2020 May; 25(10):. PubMed ID: 32443652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
    Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
    ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
    Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
    CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders.
    Saleem Khan M; Asif Nawaz M; Jalil S; Rashid F; Hameed A; Asari A; Mohamad H; Ur Rehman A; Iftikhar M; Iqbal J; Al-Rashida M
    Bioorg Chem; 2022 Jan; 118():105457. PubMed ID: 34798458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
    Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
    Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibition by selected dye compounds.
    de Beer F; Petzer JP; Petzer A
    Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation.
    Kumar S; Jaiswal S; Gupta SK; Ayyannan SR
    J Biomol Struct Dyn; 2024 Jun; 42(9):4710-4729. PubMed ID: 37345530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
    Tripathi RK; Rai GK; Ayyannan SR
    ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of Dantrolene-Like Hydrazide and Hydrazone Analogues as Multitarget Agents for Neurodegenerative Diseases.
    Bolognino I; Giangregorio N; Tonazzi A; Martínez AL; Altomare CD; Loza MI; Sablone S; Cellamare S; Catto M
    ChemMedChem; 2021 Sep; 16(18):2807-2816. PubMed ID: 34047061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
    Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
    Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
    Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
    J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
    Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
    Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
    Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
    Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
    Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study.
    Dinh Thanh N; Son Hai D; Ngoc Toan V; Thi Kim Van H; Thi Kim Giang N; Minh Tri N
    Arch Pharm (Weinheim); 2024 May; 357(5):e2300557. PubMed ID: 38321839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
    Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
    Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.